Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Total Assets of $1.10 billion for the year ending 2025.
- CATALYST PHARMACEUTICALS, INC. showed an increase of +29.7% in Total Assets from 2024 to 2025.
- This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $5.61 million | Q3 2011: $4.30 million | Q1 2012: $4.99 million | Q2 2012: $7.70 million | Q3 2012: $12.11 million | Q1 2013: $14.47 million | Q2 2013: $12.55 million | Q3 2013: $28.69 million | Q1 2014: $22.23 million | Q2 2014: $45.93 million | Q3 2014: $45.84 million | Q1 2015: $76.05 million | Q2 2015: $68.34 million | Q3 2015: $64.56 million | Q1 2016: $53.67 million | Q2 2016: $48.94 million | Q3 2016: $45.31 million | Q1 2017: $37.70 million | Q2 2017: $35.98 million | Q3 2017: $34.63 million | Q1 2018: $79.13 million | Q2 2018: $74.29 million | Q3 2018: $67.71 million | Q1 2019: $61.08 million | Q2 2019: $78.23 million | Q3 2019: $96.69 million | Q1 2020: $117.88 million | Q2 2020: $131.41 million | Q3 2020: $174.86 million | Q1 2021: $197.22 million | Q2 2021: $209.13 million | Q3 2021: $223.25 million | Q1 2022: $246.97 million | Q2 2022: $267.31 million | Q3 2022: $333.11 million | Q1 2023: $407.23 million | Q2 2023: $443.90 million | Q3 2023: $413.21 million | Q1 2024: $646.68 million | Q2 2024: $706.36 million | Q3 2024: $772.01 million | Q1 2025: $908.87 million | Q2 2025: $971.92 million | Q3 2025: $1.05 billion.
- Over the full 16 years of available data (2010 to 2025), CATALYST PHARMACEUTICALS, INC.'s Total Assets has grown by 18,831.3%.
- Historical annual values: Fiscal year 2025: $1.10 billion | Fiscal year 2024: $851.41 million | Fiscal year 2023: $470.11 million | Fiscal year 2022: $375.63 million | Fiscal year 2021: $237.79 million | Fiscal year 2020: $192.35 million | Fiscal year 2019: $112.38 million | Fiscal year 2018: $60.45 million | Fiscal year 2017: $85.39 million | Fiscal year 2016: $41.71 million | Fiscal year 2015: $60.10 million | Fiscal year 2014: $43.91 million | Fiscal year 2013: $25.37 million | Fiscal year 2012: $16.79 million | Fiscal year 2011: $6.25 million | Fiscal year 2010: $5.83 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: